A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
Spanish Registry of Systemic Treatments in Psoriasis
- Status
- RECRUITING
- Phase
- N/A
A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)
- Status
- TERMINATED
- Phase
- PHASE4
A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE1
International Expanded Access Program to Provide Ramucirumab for the Treatment of Metastatic Gastric Cancer
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
A Study of LY2835219 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
PP-Gemcitabine & External Beam Radiation-Sarcomas
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
- Status
- TERMINATED
- Phase
- PHASE3
A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of LY2969822 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2835219 in Japanese Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body
- Status
- TERMINATED
- Phase
- PHASE1
A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Galunisertib in Participants With Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study of Axiron® in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study of LY3108743 in Healthy Participants and Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1